Annual Cash & Cash Equivalents
$13.52 M
-$1.33 M-8.95%
31 December 2023
Summary:
Armata Pharmaceuticals annual cash & cash equivalents is currently $13.52 million, with the most recent change of -$1.33 million (-8.95%) on 31 December 2023. During the last 3 years, it has risen by +$3.87 million (+40.15%). ARMP annual cash & cash equivalents is now -64.99% below its all-time high of $38.63 million, reached on 31 December 2000.ARMP Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$17.14 M
-$9.26 M-35.08%
30 September 2024
Summary:
Armata Pharmaceuticals quarterly cash and cash equivalents is currently $17.14 million, with the most recent change of -$9.26 million (-35.08%) on 30 September 2024. Over the past year, it has dropped by -$6.82 million (-28.45%). ARMP quarterly cash and cash equivalents is now -63.06% below its all-time high of $46.41 million, reached on 31 March 2022.ARMP Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ARMP Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -8.9% | -28.4% |
| 3 y3 years | +40.1% | +41.9% |
| 5 y5 years | +65.8% | +97.3% |
ARMP Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -8.9% | +40.1% | -63.1% | +66.6% |
| 5 y | 5 years | -8.9% | +124.2% | -63.1% | +184.1% |
| alltime | all time | -65.0% | +1468.8% | -63.1% | +8470.5% |
Armata Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $17.14 M(-35.1%) |
| June 2024 | - | $26.41 M(-30.3%) |
| Mar 2024 | - | $37.86 M(+180.0%) |
| Dec 2023 | $13.52 M(-8.9%) | $13.52 M(-43.6%) |
| Sept 2023 | - | $23.96 M(+92.3%) |
| June 2023 | - | $12.46 M(-50.4%) |
| Mar 2023 | - | $25.11 M(+69.0%) |
| Dec 2022 | $14.85 M(+44.4%) | $14.85 M(-41.5%) |
| Sept 2022 | - | $25.38 M(-31.4%) |
| June 2022 | - | $36.98 M(-20.3%) |
| Mar 2022 | - | $46.41 M(+351.1%) |
| Dec 2021 | $10.29 M(+6.6%) | $10.29 M(-14.8%) |
| Sept 2021 | - | $12.08 M(-31.1%) |
| June 2021 | - | $17.54 M(-21.9%) |
| Mar 2021 | - | $22.45 M(+132.7%) |
| Dec 2020 | $9.65 M(+59.9%) | $9.65 M(-39.3%) |
| Sept 2020 | - | $15.88 M(-19.7%) |
| June 2020 | - | $19.79 M(-18.3%) |
| Mar 2020 | - | $24.21 M(+301.3%) |
| Dec 2019 | $6.03 M(-26.0%) | $6.03 M(-30.6%) |
| Sept 2019 | - | $8.69 M(-34.1%) |
| June 2019 | - | $13.19 M(+138.3%) |
| Mar 2019 | - | $5.54 M(-32.1%) |
| Dec 2018 | $8.16 M(+58.9%) | $8.16 M(+81.3%) |
| Sept 2018 | - | $4.50 M(-22.4%) |
| June 2018 | - | $5.80 M(-29.3%) |
| Mar 2018 | - | $8.21 M(+59.9%) |
| Dec 2017 | $5.13 M(-10.1%) | $5.13 M(-33.6%) |
| Sept 2017 | - | $7.72 M(-13.8%) |
| June 2017 | - | $8.96 M(+307.0%) |
| Mar 2017 | - | $2.20 M(-61.4%) |
| Dec 2016 | $5.71 M(-39.1%) | $5.71 M(+44.0%) |
| Sept 2016 | - | $3.97 M(-44.5%) |
| June 2016 | - | $7.14 M(+15.7%) |
| Mar 2016 | - | $6.17 M(-34.1%) |
| Dec 2015 | $9.37 M(+42.4%) | $9.37 M(-20.2%) |
| Sept 2015 | - | $11.74 M(-18.2%) |
| June 2015 | - | $14.35 M(-13.7%) |
| Mar 2015 | - | $16.63 M(+152.6%) |
| Dec 2014 | $6.58 M(-67.7%) | $6.58 M(-32.8%) |
| Sept 2014 | - | $9.79 M(-22.0%) |
| June 2014 | - | $12.55 M(-23.6%) |
| Mar 2014 | - | $16.43 M(-19.3%) |
| Dec 2013 | $20.36 M(+2261.4%) | $20.36 M(+412.2%) |
| Dec 2012 | $862.00 K(-83.5%) | - |
| Sept 2009 | - | $3.97 M(+61.0%) |
| June 2009 | - | $2.47 M(-37.0%) |
| Mar 2009 | - | $3.92 M(-24.9%) |
| Dec 2008 | $5.22 M(-68.3%) | $5.22 M(-43.2%) |
| Sept 2008 | - | $9.18 M(-27.7%) |
| June 2008 | - | $12.70 M(-1.3%) |
| Mar 2008 | - | $12.86 M(-21.8%) |
| Dec 2007 | $16.44 M | $16.44 M(-19.9%) |
| Sept 2007 | - | $20.53 M(-21.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2007 | - | $26.05 M(+131.4%) |
| Mar 2007 | - | $11.25 M(+81.3%) |
| Dec 2006 | $6.21 M(-56.1%) | $6.21 M(-33.1%) |
| Sept 2006 | - | $9.28 M(-23.8%) |
| June 2006 | - | $12.17 M(-23.9%) |
| Mar 2006 | - | $16.00 M(+13.3%) |
| Dec 2005 | $14.12 M(-58.6%) | $14.12 M(-17.7%) |
| Sept 2005 | - | $17.15 M(-33.0%) |
| June 2005 | - | $25.61 M(-15.8%) |
| Mar 2005 | - | $30.42 M(-10.8%) |
| Dec 2004 | $34.10 M(+61.9%) | $34.10 M(+8.8%) |
| Sept 2004 | - | $31.33 M(-16.2%) |
| June 2004 | - | $37.38 M(-9.1%) |
| Mar 2004 | - | $41.12 M(+95.3%) |
| Dec 2003 | $21.06 M(+67.0%) | $21.06 M(-19.4%) |
| Sept 2003 | - | $26.12 M(+5.5%) |
| June 2003 | - | $24.75 M(+102.4%) |
| Mar 2003 | - | $12.23 M(-3.0%) |
| Dec 2002 | $12.61 M(-49.9%) | $12.61 M(-27.0%) |
| Sept 2002 | - | $17.27 M(-0.0%) |
| June 2002 | - | $17.27 M(+1.5%) |
| Mar 2002 | - | $17.02 M(-32.4%) |
| Dec 2001 | $25.19 M(-34.8%) | $25.19 M(-10.6%) |
| Sept 2001 | - | $28.19 M(+6.0%) |
| June 2001 | - | $26.58 M(-21.9%) |
| Mar 2001 | - | $34.03 M(-11.9%) |
| Dec 2000 | $38.63 M(+842.2%) | $38.63 M(-0.5%) |
| Sept 2000 | - | $38.83 M(+39.0%) |
| June 2000 | - | $27.94 M(-4.8%) |
| Mar 2000 | - | $29.34 M(+615.5%) |
| Dec 1999 | $4.10 M(+115.8%) | $4.10 M(-18.0%) |
| Sept 1999 | - | $5.00 M(+150.0%) |
| June 1999 | - | $2.00 M(+233.3%) |
| Mar 1999 | - | $600.00 K(-68.4%) |
| Dec 1998 | $1.90 M(+90.0%) | $1.90 M(+11.8%) |
| Sept 1998 | - | $1.70 M(0.0%) |
| June 1998 | - | $1.70 M(+183.3%) |
| Mar 1998 | - | $600.00 K(-40.0%) |
| Dec 1997 | $1.00 M(-71.4%) | $1.00 M(-68.8%) |
| Sept 1997 | - | $3.20 M(+1500.0%) |
| June 1997 | - | $200.00 K(-77.8%) |
| Mar 1997 | - | $900.00 K(-74.3%) |
| Dec 1996 | $3.50 M(+59.1%) | $3.50 M(+59.1%) |
| Sept 1996 | - | $2.20 M(-69.4%) |
| June 1996 | - | $7.20 M(+380.0%) |
| Mar 1996 | - | $1.50 M(-31.8%) |
| Dec 1995 | $2.20 M(-4.3%) | $2.20 M(-26.7%) |
| Sept 1995 | - | $3.00 M(+900.0%) |
| June 1995 | - | $300.00 K(-40.0%) |
| Mar 1995 | - | $500.00 K(-78.3%) |
| Dec 1994 | $2.30 M(+91.7%) | $2.30 M(-36.1%) |
| Sept 1994 | - | $3.60 M(-41.0%) |
| June 1994 | - | $6.10 M(+408.3%) |
| Dec 1993 | $1.20 M | $1.20 M |
FAQ
- What is Armata Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Armata Pharmaceuticals?
- What is Armata Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Armata Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Armata Pharmaceuticals?
- What is Armata Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Armata Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of ARMP is $13.52 M
What is the all time high annual cash & cash equivalents for Armata Pharmaceuticals?
Armata Pharmaceuticals all-time high annual cash & cash equivalents is $38.63 M
What is Armata Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, ARMP annual cash & cash equivalents has changed by -$1.33 M (-8.95%)
What is Armata Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ARMP is $17.14 M
What is the all time high quarterly cash and cash equivalents for Armata Pharmaceuticals?
Armata Pharmaceuticals all-time high quarterly cash and cash equivalents is $46.41 M
What is Armata Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, ARMP quarterly cash and cash equivalents has changed by -$6.82 M (-28.45%)